Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease
Launched by RENMIN HOSPITAL OF WUHAN UNIVERSITY · May 31, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on collecting and storing samples from patients with colorectal cancer and gastric cancer, as well as from patients with non-cancerous conditions like inflammatory bowel disease, gastric ulcers, hemorrhoids, or hernias. The goal is to gather blood and tissue samples, which will help researchers create a database that includes important clinical information. This database will be valuable for current and future studies aimed at understanding these conditions better and improving treatments.
To participate in this study, you should be a patient diagnosed with colorectal cancer, gastric cancer, or any of the non-malignant diseases mentioned, and you must be undergoing surgery. It's important that you are willing to provide your consent to participate. If you have other health issues that might interfere with treatment or diagnosis, you may not be eligible. If you join the trial, you can expect to contribute to important research that could benefit future patients while helping scientists learn more about these medical conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any patient diagnosed with colorectal cancer, gastric cancer, non-malignant disease that requires undergoing surgery.
- • Must be willing and able to provide informed consent.
- Exclusion Criteria:
- • Subjects whose comorbidities would preclude diagnostic or therapeutic intervention.
About Renmin Hospital Of Wuhan University
Renmin Hospital of Wuhan University is a leading healthcare institution in China, renowned for its commitment to advancing medical research and clinical innovation. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in various medical fields to facilitate cutting-edge studies aimed at improving patient outcomes and healthcare practices. With a strong emphasis on ethical standards and patient safety, Renmin Hospital collaborates with various stakeholders to drive forward-thinking research initiatives that contribute to the global medical community. Its state-of-the-art facilities and multidisciplinary teams enable efficient trial execution, ensuring robust data collection and analysis in pursuit of transformative healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
Patients applied
Trial Officials
Tao Fu, MD
Principal Investigator
Renmin Hospital of Wuhan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials